Biopharmaceutical Company Beats Patient Start Goal by 3.7X

[SUCCESS STORY]

Connecting Rare Disease Patients to Life-Altering Treatment: Biopharmaceutical Company Beats Patient Start Goal by 3.7X in 6 Months

Improving Lives, One Patient at a Time

WHAT WE DO

Patient Engagement

Patient Education

Onmichannel Outreach

Team Selling

INDUSTRY

Healthcare | Rare Disease

RESULTS

3.7X Patient Start Goal in 6 Months

Re-Engaged 24% of Previously Inactive Patients

8:1 Annual Revenue ROI

Critical Patient Funnel Gap Caused Missed Opportunities for Life-Altering Care and Revenue

[SITUATION]

Our client, a global biotechnology leader in ultra rare genetic disease therapies, offers symptom management treatment for Phenylketonuria (PKU), an incurable disease that affects one out of every 10,000 babies born in the U.S. each year. Our client faced a silent but costly challenge: nearly 3,000 of its patients had taken the first step toward receiving life-altering care by signing a patient authorization form, but those patients never initiated therapy. Each stagnated patient journey represented not only lost revenue but a missed opportunity to deliver life-changing treatment to patients who needed it most. Our client engaged MarketSource to fill these critical gaps in their patient funnel, reignite patient journey momentum, and grow revenue.

CHALLENGES


Stagnant patient journey

Waning patient engagement

Lack of personalized patient outreach

“What your team is doing is incredible. This program is having an impact on our revenue and, most importantly, on patient’s lives! We really appreciate your team’s efforts! You all are making a difference—one patient at a time.”
– Sr. Director, rare disease biopharmaceutical company

KEYS TO SUCCESS


Clinical patient engagement + education specialists

Personalized omnichannel outreach

Clinical Patient Education Specialists Re-Engaged Patients, Accelerating Therapy Initiation

[SOLUTION]

Using a team-sell approach, our clinical Patient Education Specialists worked with the client’s field sales team to connect patients to essential therapies. These specialists, clinicians who were also subject matter experts in the client’s at-home injectable therapy, engaged patients with motivational interviewing—a technique healthcare providers and counselors use to help patients overcome their ambivalent feelings about treatment and encourage them to find the motivation to take the next step in their care.

The team used a personalized, omnichannel outreach strategy to connect with patients in resonant ways and empower them to better understand their condition, evaluate their treatment options, and take confident steps toward effective therapy.

Real-World Results

3.7X Patient Start Goal in 6 Months

Re-Engaged 24% of Previously Inactive Patients

8:1 Annual Revenue ROI

Within six months, our team’s skilled, expanded outreach re-engaged 24% of previously inactive patients, resulting in 11 new patient starts, 3.7X the client’s original goal, and an 8:1 annual revenue return on investment for the client.